Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Key Considerations Before Investing in PAYX

Now trading at a price of $132.26, Paychex has moved -2.1% so far today.

Over the last year, Paychex logged a -0.1% change, with its stock price reaching a high of $161.24 and a low of $131.83. Over the same period, the stock underperformed the S&P 500 index by -16.9%. AThe company's 50-day average price was $140.59. Paychex, Inc., together with its subsidiaries, provides human capital management solutions (HCM) for payroll, employee benefits, human resources (HR), and insurance services for small to medium-sized businesses in the United States, Europe, and India. Based in Rochester, NY, the Large-Cap Industrials company has 19,000 full time employees. Paychex has offered a 3.0% dividend yield over the last 12 months.

Growing Revenues but an Average Current Ratio:

2019 2020 2021 2022 2023 2024
Revenue (M) $4,040 $4,057 $4,612 $5,007 $5,278 $5,572
Operating Margins 36% 36% 40% 41% 41% 40%
Net Margins 27% 27% 30% 31% 32% 30%
Net Income (M) $1,098 $1,098 $1,393 $1,557 $1,690 $1,657
Net Interest Expense (M) -$23 -$26 -$15 $15 $44 $38
Depreciation & Amort. (M) $128 $123 $192 $177 $176 $119
Diluted Shares (M) 362 363 362 362 362 362
Earnings Per Share $3.04 $3.03 $3.84 $4.3 $4.67 $4.58
EPS Growth n/a -0.33% 26.73% 11.98% 8.6% -1.93%
Avg. Price $72.89 $72.3 $102.15 $119.84 $119.11 $132.56
P/E Ratio 23.82 23.7 26.46 27.74 25.4 28.82
Free Cash Flow (M) $1,314 $1,142 $1,456 $1,563 $1,736 $1,709
CAPEX (M) $127 $118 $134 $143 $161 $192
EV / EBITDA 16.53 16.52 17.95 19.3 18.08 22.12
Total Debt (M) $797 $797 $798 $798 $799 $5,348
Net Debt / EBITDA 0.07 0.1 -0.15 -0.26 -0.17 1.6
Current Ratio 1.28 1.27 1.3 1.23 1.39 1.28

Paychex benefits from growing revenues and increasing reinvestment in the business, strong operating margins with a stable trend, and generally positive cash flows. The company's financial statements show positive EPS growth and healthy leverage levels. Furthermore, Paychex has just enough current assets to cover current liabilities, as shown by its current ratio of 1.28.

Paychex Has Elevated P/B and P/E Ratios:

Paychex has a trailing twelve month P/E ratio of 30.7, compared to an average of 24.03 for the Industrials sector. Based on its EPS guidance of $5.29, the company has a forward P/E ratio of 26.6. The 8.2% compound average growth rate of Paychex's historical and projected earnings per share yields a PEG ratio of 3.73. This suggests that these shares are overvalued. Furthermore, Paychex is likely overvalued compared to the book value of its equity, since its P/B ratio of 11.55 is higher than the sector average of 2.89. The company's shares are currently trading 285.8% below their Graham number. Overall, Paychex's lofty valuation in terms of earnings and assets is to some extent attenuated by its strong cash flow trend and reasonable levels of debt.

Paychex Has an Average Rating of Hold:

The 12 analysts following Paychex have set target prices ranging from $122.0 to $160.0 per share, for an average of $146.58 with a hold rating. The company is trading -9.8% away from its average target price, indicating that there is an analyst consensus of some upside potential.

Paychex has an average amount of shares sold short because 3.9% of the company's shares are sold short. Institutions own 81.5% of the company's shares, and the insider ownership rate stands at 10.62%, suggesting a large amount of insider shareholders. The largest shareholder is Vanguard Group Inc, whose 9% stake in the company is worth $4,260,882,295.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS